Friday - December 19, 2025

Use of McT1 Inhibitors to Enhance Insulin Sensitivity

2025-12-09

ALEXANDRIA, Virginia, Dec. 9 -- H. LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE, INC., Tampa, Florida has been assigned a patent (No. US 12491187 B2, initially filed Dec. 21, 2022) developed by Patricia McDonald, Land O Lakes, Florida, and Tracey Bailey, Tampa, Florida, for "Use of MCT1 inhibitors to enhance insulin sensitivity." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Use of McT1 Inhibitors to Enhance Insulin Sensitivity

Information Request Form

Copyright Targeted News Service 2025